Variables | Derivation cohort n(%) | Validation cohort n(%) | p-values |
---|---|---|---|
Patients’ age (in years)a | 4.65 (3—9.75) | 8 (5—10) | 0.130 |
Gender | |||
Male | 35(62.5) | 19(61.3) | 0.911 |
Female | 21(37.5) | 12(38.7) | |
Blood group | |||
A + | 9(16.1) | 10(32.3) | b0.406 |
B + | 15(26.8) | 5(16.1) | |
A- | 1(1.8) | 0(0) | |
AB + | 7(12.5) | 2(6.5) | |
AB- | 1(1.8) | 0(0) | |
O + | 21(37.5) | 14(45.2) | |
O- | 2(3.6) | 0(0) | |
Disease category | |||
Beta-Thalassemia Major | 38(67.9) | 21(67.7) | 0.991 |
Aplastic anemia | 18(32.1) | 10(32.3) | |
Platelet count on day 14a | 22 (9 – 50) | 14 (7 – 42) | 0.555 |
Platelet count on engraftment day | 34(22–110) | ||
Platelet Engraftment Daysa | 17.5 (14—22.5) | 16 (13—21) | 0.835 |